Review



plc inhibitor d609  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress plc inhibitor d609
    Plc Inhibitor D609, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plc inhibitor d609/product/MedChemExpress
    Average 94 stars, based on 10 article reviews
    plc inhibitor d609 - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    MedChemExpress plc inhibitor d609
    Plc Inhibitor D609, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plc inhibitor d609/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    plc inhibitor d609 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Tocris plc inhibitor d609
    Phosphatidyl 4,5-bisphosphate concentrations are altered after oxaliplatin treatment. ( A ) Relative PIP 2 (phosphatidylinositol 4,5-bisphosphate) concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells treated with vehicle (saline) or 10 µM oxaliplatin for 24 h. Data represent the means ± SEM from n = 10–12 dishes per condition. * p < 0.05; *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( B ) Relative PIP 2 concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells that were treated with vehicle (saline), 10 µM oxaliplatin ±10 µM of the <t>PLC</t> inhibitor <t>D609</t> for 5 h. Data represent the means ± SEM from n = 4–6 dishes per condition. *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( C ) Schematic overview of the proposed mechanisms leading to TRPM8 channel desensitization after acute oxaliplatin treatment. TRPM8 channel activation causes PLC pathway activation. In turn, PLC hydrolyzes PIP 2 to IP 3 (inositol 1,4,5-triphosphate) and DAG (1,2-diacylglycerol). PIP 2 -depletion is responsible for TRPM8 channel desensitization after oxaliplatin treatment.
    Plc Inhibitor D609, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plc inhibitor d609/product/Tocris
    Average 93 stars, based on 1 article reviews
    plc inhibitor d609 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Tocris plc inhibitors d609
    Phosphatidyl 4,5-bisphosphate concentrations are altered after oxaliplatin treatment. ( A ) Relative PIP 2 (phosphatidylinositol 4,5-bisphosphate) concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells treated with vehicle (saline) or 10 µM oxaliplatin for 24 h. Data represent the means ± SEM from n = 10–12 dishes per condition. * p < 0.05; *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( B ) Relative PIP 2 concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells that were treated with vehicle (saline), 10 µM oxaliplatin ±10 µM of the <t>PLC</t> inhibitor <t>D609</t> for 5 h. Data represent the means ± SEM from n = 4–6 dishes per condition. *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( C ) Schematic overview of the proposed mechanisms leading to TRPM8 channel desensitization after acute oxaliplatin treatment. TRPM8 channel activation causes PLC pathway activation. In turn, PLC hydrolyzes PIP 2 to IP 3 (inositol 1,4,5-triphosphate) and DAG (1,2-diacylglycerol). PIP 2 -depletion is responsible for TRPM8 channel desensitization after oxaliplatin treatment.
    Plc Inhibitors D609, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plc inhibitors d609/product/Tocris
    Average 93 stars, based on 1 article reviews
    plc inhibitors d609 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Millipore pc-plc inhibitor o-tricyclo[5.2.1.02,6]dec-9-yl dithiocarbonate (d609)
    Phosphatidyl 4,5-bisphosphate concentrations are altered after oxaliplatin treatment. ( A ) Relative PIP 2 (phosphatidylinositol 4,5-bisphosphate) concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells treated with vehicle (saline) or 10 µM oxaliplatin for 24 h. Data represent the means ± SEM from n = 10–12 dishes per condition. * p < 0.05; *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( B ) Relative PIP 2 concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells that were treated with vehicle (saline), 10 µM oxaliplatin ±10 µM of the <t>PLC</t> inhibitor <t>D609</t> for 5 h. Data represent the means ± SEM from n = 4–6 dishes per condition. *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( C ) Schematic overview of the proposed mechanisms leading to TRPM8 channel desensitization after acute oxaliplatin treatment. TRPM8 channel activation causes PLC pathway activation. In turn, PLC hydrolyzes PIP 2 to IP 3 (inositol 1,4,5-triphosphate) and DAG (1,2-diacylglycerol). PIP 2 -depletion is responsible for TRPM8 channel desensitization after oxaliplatin treatment.
    Pc Plc Inhibitor O Tricyclo[5.2.1.02,6]Dec 9 Yl Dithiocarbonate (D609), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pc-plc inhibitor o-tricyclo[5.2.1.02,6]dec-9-yl dithiocarbonate (d609)/product/Millipore
    Average 90 stars, based on 1 article reviews
    pc-plc inhibitor o-tricyclo[5.2.1.02,6]dec-9-yl dithiocarbonate (d609) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Tocris phosphatidyl choline specific phospholipase c pc plc inhibitor
    Phosphatidyl 4,5-bisphosphate concentrations are altered after oxaliplatin treatment. ( A ) Relative PIP 2 (phosphatidylinositol 4,5-bisphosphate) concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells treated with vehicle (saline) or 10 µM oxaliplatin for 24 h. Data represent the means ± SEM from n = 10–12 dishes per condition. * p < 0.05; *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( B ) Relative PIP 2 concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells that were treated with vehicle (saline), 10 µM oxaliplatin ±10 µM of the <t>PLC</t> inhibitor <t>D609</t> for 5 h. Data represent the means ± SEM from n = 4–6 dishes per condition. *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( C ) Schematic overview of the proposed mechanisms leading to TRPM8 channel desensitization after acute oxaliplatin treatment. TRPM8 channel activation causes PLC pathway activation. In turn, PLC hydrolyzes PIP 2 to IP 3 (inositol 1,4,5-triphosphate) and DAG (1,2-diacylglycerol). PIP 2 -depletion is responsible for TRPM8 channel desensitization after oxaliplatin treatment.
    Phosphatidyl Choline Specific Phospholipase C Pc Plc Inhibitor, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphatidyl choline specific phospholipase c pc plc inhibitor/product/Tocris
    Average 93 stars, based on 1 article reviews
    phosphatidyl choline specific phospholipase c pc plc inhibitor - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Enzo Biochem phospholipase d (pld) and phosphatidylcholine-specific plc (pc-plc) inhibitor d609 ( 29 ) at 300 μm
    Phosphatidyl 4,5-bisphosphate concentrations are altered after oxaliplatin treatment. ( A ) Relative PIP 2 (phosphatidylinositol 4,5-bisphosphate) concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells treated with vehicle (saline) or 10 µM oxaliplatin for 24 h. Data represent the means ± SEM from n = 10–12 dishes per condition. * p < 0.05; *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( B ) Relative PIP 2 concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells that were treated with vehicle (saline), 10 µM oxaliplatin ±10 µM of the <t>PLC</t> inhibitor <t>D609</t> for 5 h. Data represent the means ± SEM from n = 4–6 dishes per condition. *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( C ) Schematic overview of the proposed mechanisms leading to TRPM8 channel desensitization after acute oxaliplatin treatment. TRPM8 channel activation causes PLC pathway activation. In turn, PLC hydrolyzes PIP 2 to IP 3 (inositol 1,4,5-triphosphate) and DAG (1,2-diacylglycerol). PIP 2 -depletion is responsible for TRPM8 channel desensitization after oxaliplatin treatment.
    Phospholipase D (Pld) And Phosphatidylcholine Specific Plc (Pc Plc) Inhibitor D609 ( 29 ) At 300 μm, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phospholipase d (pld) and phosphatidylcholine-specific plc (pc-plc) inhibitor d609 ( 29 ) at 300 μm/product/Enzo Biochem
    Average 90 stars, based on 1 article reviews
    phospholipase d (pld) and phosphatidylcholine-specific plc (pc-plc) inhibitor d609 ( 29 ) at 300 μm - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Biomol GmbH pc-plc inhibitor d609
    Phosphatidyl 4,5-bisphosphate concentrations are altered after oxaliplatin treatment. ( A ) Relative PIP 2 (phosphatidylinositol 4,5-bisphosphate) concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells treated with vehicle (saline) or 10 µM oxaliplatin for 24 h. Data represent the means ± SEM from n = 10–12 dishes per condition. * p < 0.05; *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( B ) Relative PIP 2 concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells that were treated with vehicle (saline), 10 µM oxaliplatin ±10 µM of the <t>PLC</t> inhibitor <t>D609</t> for 5 h. Data represent the means ± SEM from n = 4–6 dishes per condition. *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( C ) Schematic overview of the proposed mechanisms leading to TRPM8 channel desensitization after acute oxaliplatin treatment. TRPM8 channel activation causes PLC pathway activation. In turn, PLC hydrolyzes PIP 2 to IP 3 (inositol 1,4,5-triphosphate) and DAG (1,2-diacylglycerol). PIP 2 -depletion is responsible for TRPM8 channel desensitization after oxaliplatin treatment.
    Pc Plc Inhibitor D609, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pc-plc inhibitor d609/product/Biomol GmbH
    Average 90 stars, based on 1 article reviews
    pc-plc inhibitor d609 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Millipore d609 (phosphatidylcholine-specific [pc-plc] inhibitor)
    Phosphatidyl 4,5-bisphosphate concentrations are altered after oxaliplatin treatment. ( A ) Relative PIP 2 (phosphatidylinositol 4,5-bisphosphate) concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells treated with vehicle (saline) or 10 µM oxaliplatin for 24 h. Data represent the means ± SEM from n = 10–12 dishes per condition. * p < 0.05; *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( B ) Relative PIP 2 concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells that were treated with vehicle (saline), 10 µM oxaliplatin ±10 µM of the <t>PLC</t> inhibitor <t>D609</t> for 5 h. Data represent the means ± SEM from n = 4–6 dishes per condition. *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( C ) Schematic overview of the proposed mechanisms leading to TRPM8 channel desensitization after acute oxaliplatin treatment. TRPM8 channel activation causes PLC pathway activation. In turn, PLC hydrolyzes PIP 2 to IP 3 (inositol 1,4,5-triphosphate) and DAG (1,2-diacylglycerol). PIP 2 -depletion is responsible for TRPM8 channel desensitization after oxaliplatin treatment.
    D609 (Phosphatidylcholine Specific [Pc Plc] Inhibitor), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d609 (phosphatidylcholine-specific [pc-plc] inhibitor)/product/Millipore
    Average 90 stars, based on 1 article reviews
    d609 (phosphatidylcholine-specific [pc-plc] inhibitor) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Phosphatidyl 4,5-bisphosphate concentrations are altered after oxaliplatin treatment. ( A ) Relative PIP 2 (phosphatidylinositol 4,5-bisphosphate) concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells treated with vehicle (saline) or 10 µM oxaliplatin for 24 h. Data represent the means ± SEM from n = 10–12 dishes per condition. * p < 0.05; *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( B ) Relative PIP 2 concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells that were treated with vehicle (saline), 10 µM oxaliplatin ±10 µM of the PLC inhibitor D609 for 5 h. Data represent the means ± SEM from n = 4–6 dishes per condition. *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( C ) Schematic overview of the proposed mechanisms leading to TRPM8 channel desensitization after acute oxaliplatin treatment. TRPM8 channel activation causes PLC pathway activation. In turn, PLC hydrolyzes PIP 2 to IP 3 (inositol 1,4,5-triphosphate) and DAG (1,2-diacylglycerol). PIP 2 -depletion is responsible for TRPM8 channel desensitization after oxaliplatin treatment.

    Journal: International Journal of Molecular Sciences

    Article Title: Oxaliplatin Causes Transient Changes in TRPM8 Channel Activity

    doi: 10.3390/ijms22094962

    Figure Lengend Snippet: Phosphatidyl 4,5-bisphosphate concentrations are altered after oxaliplatin treatment. ( A ) Relative PIP 2 (phosphatidylinositol 4,5-bisphosphate) concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells treated with vehicle (saline) or 10 µM oxaliplatin for 24 h. Data represent the means ± SEM from n = 10–12 dishes per condition. * p < 0.05; *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( B ) Relative PIP 2 concentrations of untransfected HEK cells, empty-vector-transfected and TRPM8-transfected HEK cells that were treated with vehicle (saline), 10 µM oxaliplatin ±10 µM of the PLC inhibitor D609 for 5 h. Data represent the means ± SEM from n = 4–6 dishes per condition. *** p < 0.001; one-way ANOVA and Dunnett´s multiple comparison test. ( C ) Schematic overview of the proposed mechanisms leading to TRPM8 channel desensitization after acute oxaliplatin treatment. TRPM8 channel activation causes PLC pathway activation. In turn, PLC hydrolyzes PIP 2 to IP 3 (inositol 1,4,5-triphosphate) and DAG (1,2-diacylglycerol). PIP 2 -depletion is responsible for TRPM8 channel desensitization after oxaliplatin treatment.

    Article Snippet: For PI (4,5) P2 ELISA measurement analysis, (r)TRPM8-transfected or empty-vector-transfected and untransfected HEK cells were treated with 10 μM oxaliplatin for 24 h. For investigating the contribution of the PLC pathway to the PIP 2 amount, (r)TRPM8-transfected or empty-vector-transfected and untransfected HEK cells were treated with 10 μM oxaliplatin ±10 μM of the PLC inhibitor D609 (Tocris) for 5 h.

    Techniques: Plasmid Preparation, Transfection, Saline, Comparison, Activation Assay